Alec P. Pankow
Alec is a Ph.D. Student in the Rosenberg lab. He earned a B.S. in biochemistry from the University of Puget Sound in Tacoma, Washington before going on to work as a molecular biology research technician at the University of Washington in Seattle and a bioinformatician at Karolinska Institute in Stockholm, Sweden. At UW, Alec studied HIV pathogenesis and latency in Dr. Jim Mullins’ molecular retrovirology laboratory. While there, he helped develop a bench protocol and computational pipeline which used PacBio long-read sequencing for accurate assessment of viral quasispecies. After joining Dr. Benjamin Murrell’s group at Karolinska in the Spring of 2020, Alec leveraged camelid single-domain antibody (or nanobody) repertoire sequencing to predict neutralizing antibody candidates against SARS-CoV-2 spike protein. As a graduate student in the Rosenberg lab, he is now focused on technology development for high-content CRISPR screens and model culture systems for studying respiratory virus infection.
Outside the lab, Alec enjoys exploring New York City on foot and scrolling though bike ads online.
![_DSF2499](https://labs.icahn.mssm.edu/rosenberglab/wp-content/uploads/sites/234/2022/09/DSF2499.jpeg)
![_DSF2499](https://labs.icahn.mssm.edu/rosenberglab/wp-content/uploads/sites/234/2022/09/DSF2499-300x300.jpeg)
Alec P. Pankow
Alec is a Ph.D. Student in the Rosenberg lab. He earned a B.S. in biochemistry from the University of Puget Sound in Tacoma, Washington before going on to work as a molecular biology research technician at the University of Washington in Seattle and a bioinformatician at Karolinska Institute in Stockholm, Sweden. At UW, Alec studied HIV pathogenesis and latency in Dr. Jim Mullins’ molecular retrovirology laboratory. While there, he helped develop a bench protocol and computational pipeline which used PacBio long-read sequencing for accurate assessment of viral quasispecies. After joining Dr. Benjamin Murrell’s group at Karolinska in the Spring of 2020, Alec leveraged camelid single-domain antibody (or nanobody) repertoire sequencing to predict neutralizing antibody candidates against SARS-CoV-2 spike protein. As a graduate student in the Rosenberg lab, he is now focused on technology development for high-content CRISPR screens and model culture systems for studying respiratory virus infection.
Outside the lab, Alec enjoys exploring New York City on foot and scrolling though bike ads online.